UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Chromosomal copy number and mutational status are required to authenticate ovarian cancer cell lines as appropriate cell models

Molecular biology reports, 2024-12, Vol.51 (1), p.784, Article 784

2024

Volltextzugriff (PDF)

Proteomic time course of breast cancer cells highlights enhanced sensitivity to Stat3 and Src inhibitors prior to endocrine resistance development

Cancer gene therapy, 2023-02, Vol.30 (2), p.324-334

2023

Volltextzugriff (PDF)

Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer

Journal of translational medicine, 2021-05, Vol.19 (1), p.184-184, Article 184

2021

Volltextzugriff (PDF)

BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors

British journal of cancer, 2022-08, Vol.127 (3), p.488-499

2022

Volltextzugriff (PDF)

Indigenous and democratic decision-making: issues from community-based ecotourism in the Boumā National Heritage Park, Fiji

Journal of sustainable tourism, 2011-09, Vol.19 (7), p.817-835

Farrelly, Trisia Angela

2011

Volltextzugriff (PDF)

Preclinical evaluation of the CDK4/6 inhibitor palbociclib in combination with a PI3K or MEK inhibitor in colorectal cancer

Cancer biology & therapy, 2023-12, Vol.24 (1), p.2223388-2223388

2023

Volltextzugriff (PDF)

BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation

Molecular oncology, 2013-06, Vol.7 (3), p.567-579

2013

Volltextzugriff (PDF)

Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples

Journal of translational medicine, 2020-02, Vol.18 (1), p.99-14, Article 99

2020

Volltextzugriff (PDF)

Design, synthesis and evaluation of novel 2,2-dimethyl-2,3-dihydroquinolin-4(1H)-one based chalcones as cytotoxic agents

Heliyon, 2018-09, Vol.4 (9), p.e00767-e00767, Article e00767

2018

Volltextzugriff (PDF)

Combined Targeted Resequencing of Cytosine DNA Methylation and Mutations of DNA Repair Genes with Potential Use for Poly(ADP-Ribose) Polymerase 1 Inhibitor Sensitivity Testing

The Journal of molecular diagnostics : JMD, 2019-03, Vol.21 (2), p.198-213

2019

Volltextzugriff (PDF)

AMP-activated Protein Kinase Mediates Apoptosis in Response to Bioenergetic Stress through Activation of the Pro-apoptotic Bcl-2 Homology Domain-3-only Protein BMF

The Journal of biological chemistry, 2010-11, Vol.285 (46), p.36199-36206

2010

Volltextzugriff (PDF)

INS-1 Cells Undergoing Caspase-Dependent Apoptosis Enhance the Regenerative Capacity of Neighboring Cells

Diabetes (New York, N.Y.), 2010-11, Vol.59 (11), p.2799-2808

2010

Volltextzugriff (PDF)

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer

Obstetrics & Gynecology Science, 2020, 63(5), 653, pp.643-654

2020

Volltextzugriff (PDF)

Bone Morphogenetic Protein 3 Controls Insulin Gene Expression and Is Down-regulated in INS-1 Cells Inducibly Expressing a Hepatocyte Nuclear Factor 1A–Maturity-onset Diabetes of the Young Mutation

The Journal of biological chemistry, 2011-07, Vol.286 (29), p.25719-25728

2011

Volltextzugriff (PDF)

Rapamycin protects against dominant negative-HNF1A-induced apoptosis in INS-1 cells

Apoptosis (London), 2011-11, Vol.16 (11), p.1128-1137

2011

Volltextzugriff (PDF)

Chemotactic, mitogenic, and angiogenic actions of UTP on vascular endothelial cells

American journal of physiology. Heart and circulatory physiology, 1999-03, Vol.276 (3), p.H1091-H1097

1999

Volltextzugriff (PDF)

Abstract P1-19-24: A phase Ib trial of copanlisib in combination with trastuzumab in pretreated recurrent or metastatic HER2-positive breast cancer “PantHER”

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P1-P1-19-24

2020

Volltextzugriff (PDF)

Provisions for community participation in heritage management: case of the Zambezi Source National Monument, Zambia

International journal of heritage studies : IJHS, 2019-03, Vol.25 (3), p.225-238

2019

Volltextzugriff (PDF)

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer

Obstetrics & gynecology science, 2020-09, Vol.63 (5), p.643

2020

Volltextzugriff (PDF)

Kerekere and indigenous social entrepreneurship

Sites (Palmerston North, N.Z.), 2013-12, Vol.10 (2), p.1-29

2013

Volltextzugriff (PDF)

Cloning, expression and function of Kv11.1 variants in the human jejunum

Farrelly, Angela M

2004

Volltextzugriff (PDF)

Chemotactic, mitogenic, and angiogenic actions of UTP on vascular endothelial cells

American journal of physiology. Heart and circulatory physiology, 1999-03, Vol.45 (3), p.H1091-H1097

1999

Volltextzugriff (PDF)

Chemotactic, mitogenic, and angiogenic actions of UTP on vascular endothelial cells

American journal of physiology. Heart and circulatory physiology, 1999-03, Vol.276 (3), p.H1091

1999

Volltextzugriff (PDF)

Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2020-03, Vol.106 (4), p.733-742

2020

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(30)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(19)
Humans
(11)
Mutation
(8)
Oncology
(7)
Animals
(6)
Signal Transduction
(6)
Apoptosis
(5)
Cell Line, Tumor
(5)
Ovarian Cancer
(5)
Patients
(5)
Tumors
(5)
Biochemistry & Molecular Biology
(4)
Breast Cancer
(4)
Cancer Research
(4)
Chemotherapy
(4)
Diabetes
(4)
Hepatocyte Nuclear Factor 1-Alpha - Genetics
(4)
Metastasis
(4)
Proteins
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Chromosomal copy number and mutational status are required to authenticate ovarian cancer cell lines as appropriate cell models

Proteomic time course of breast cancer cells highlights enhanced sensitivity to Stat3 and Src inhibitors prior to endocrine resistance development

Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer

BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors

Indigenous and democratic decision-making: issues from community-based ecotourism in the Boumā National Heritage Park, Fiji

Preclinical evaluation of the CDK4/6 inhibitor palbociclib in combination with a PI3K or MEK inhibitor in colorectal cancer

BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation

Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples

Design, synthesis and evaluation of novel 2,2-dimethyl-2,3-dihydroquinolin-4(1H)-one based chalcones as cytotoxic agents

Combined Targeted Resequencing of Cytosine DNA Methylation and Mutations of DNA Repair Genes with Potential Use for Poly(ADP-Ribose) Polymerase 1 Inhibitor Sensitivity Testing

Phase Ib Trial of Copanlisib, A Phosphoinositide-3 Kinase (PI3K) Inhibitor, with Trastuzumab in Advanced Pre-Treated HER2-Positive Breast Cancer "PantHER"

AMP-activated Protein Kinase Mediates Apoptosis in Response to Bioenergetic Stress through Activation of the Pro-apoptotic Bcl-2 Homology Domain-3-only Protein BMF

INS-1 Cells Undergoing Caspase-Dependent Apoptosis Enhance the Regenerative Capacity of Neighboring Cells

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer

Bone Morphogenetic Protein 3 Controls Insulin Gene Expression and Is Down-regulated in INS-1 Cells Inducibly Expressing a Hepatocyte Nuclear Factor 1A–Maturity-onset Diabetes of the Young Mutation

Rapamycin protects against dominant negative-HNF1A-induced apoptosis in INS-1 cells

Chemotactic, mitogenic, and angiogenic actions of UTP on vascular endothelial cells

Abstract P1-19-24: A phase Ib trial of copanlisib in combination with trastuzumab in pretreated recurrent or metastatic HER2-positive breast cancer “PantHER”

Provisions for community participation in heritage management: case of the Zambezi Source National Monument, Zambia

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer

Kerekere and indigenous social entrepreneurship

Cloning, expression and function of Kv11.1 variants in the human jejunum

Chemotactic, mitogenic, and angiogenic actions of UTP on vascular endothelial cells

Chemotactic, mitogenic, and angiogenic actions of UTP on vascular endothelial cells

Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung Cancer

Suchergebnisse filtern